Other specified diseases of liver
ICD-10 K76.89 is a billable code used to indicate a diagnosis of other specified diseases of liver.
K76.89 refers to 'Other specified diseases of liver,' which encompasses a variety of liver conditions that do not fall under more specific categories. Clinically, patients may present with symptoms such as jaundice, abdominal pain, fatigue, and ascites. The liver, a vital organ in the digestive system, plays a key role in metabolism, detoxification, and bile production. Diseases classified under this code may include conditions like hepatic fibrosis, hepatic steatosis not classified elsewhere, and other liver disorders that are not specifically defined in the ICD-10 coding system. Disease progression can vary widely; some conditions may remain asymptomatic for years, while others can lead to significant liver dysfunction or cirrhosis. Diagnostic considerations include liver function tests, imaging studies such as ultrasound or CT scans, and sometimes liver biopsy to ascertain the underlying pathology. Accurate diagnosis is crucial for appropriate management and treatment planning.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
K76.89 covers a range of liver diseases that are not specifically classified elsewhere, including but not limited to hepatic fibrosis, non-alcoholic fatty liver disease, and other unspecified liver disorders. Each condition may have distinct diagnostic criteria and management strategies.
K76.89 should be used when a patient presents with liver disease that does not fit into more specific categories. It is important to document the clinical findings and rationale for using this code to avoid misclassification.
Documentation should include a comprehensive history and physical examination, results from liver function tests, imaging studies, and any relevant biopsies. Clear clinical reasoning for the diagnosis and treatment plan is essential to support the use of K76.89.
